A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months.

A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months.

Item
http://www.wikidata.org/entity/Q44094296
Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawalPharmacological strategies for detoxification.Does naltrexone affect craving in abstinent opioid-dependent patients?Rapid opiate detoxification and antagonist induction under general anaesthesia or intravenous sedation is humane, sometimes essential and should always be an option. Three illustrative case reports involving diabetes and epilepsy and a review of theClinical safety of 1500 mg oral naltrexone overdose.Pharmacologic treatments for opioid dependence: detoxification and maintenance options.Preparation and investigation of sustained drug delivery systems using an injectable, thermosensitive, in situ forming hydrogel composed of PLGA-PEG-PLGA.A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance.Effects of Pharmacotherapies for Opioid Dependence on Participants' Criminal Behaviour and Expenditure on Illicit Drugs: An Australian National Evaluation (NEPOD)
P2860

A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months.

Item
http://www.wikidata.org/entity/Q44094296
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
A comparison of antagonist-pre ...... : outcomes at 6 and 12 months.
@en
A comparison of antagonist-pre ...... : outcomes at 6 and 12 months.
@nl
type
label
A comparison of antagonist-pre ...... : outcomes at 6 and 12 months.
@en
A comparison of antagonist-pre ...... : outcomes at 6 and 12 months.
@nl
prefLabel
A comparison of antagonist-pre ...... : outcomes at 6 and 12 months.
@en
A comparison of antagonist-pre ...... : outcomes at 6 and 12 months.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
A comparison of antagonist-pre ...... : outcomes at 6 and 12 months.
@en
P2093
P304
P31
P356
10.1016/S0376-8716(02)00077-7
P433
P478
P50
P577
P698
P921